- Home
- SOTK vs CRVO Comparison
SOTK vs CRVO Comparison
Compare SOTK & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOTK
- CRVO
- Stock Information
- Founded
- SOTK 1975
- CRVO 2001
- Country
- SOTK United States
- CRVO United States
- Employees
- SOTK N/A
- CRVO N/A
- Industry
- SOTK Industrial Machinery/Components
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SOTK Technology
- CRVO Health Care
- Exchange
- SOTK Nasdaq
- CRVO Nasdaq
- Market Cap
- SOTK 58.5M
- CRVO 67.4M
- IPO Year
- SOTK 1987
- CRVO N/A
- Fundamental
- Price
- SOTK $3.66
- CRVO $6.96
- Analyst Decision
- SOTK Hold
- CRVO Strong Buy
- Analyst Count
- SOTK 1
- CRVO 7
- Target Price
- SOTK N/A
- CRVO $19.33
- AVG Volume (30 Days)
- SOTK 5.4K
- CRVO 162.5K
- Earning Date
- SOTK 07-10-2025
- CRVO 08-08-2025
- Dividend Yield
- SOTK N/A
- CRVO N/A
- EPS Growth
- SOTK N/A
- CRVO N/A
- EPS
- SOTK 0.09
- CRVO N/A
- Revenue
- SOTK $20,606,116.00
- CRVO $9,308,215.00
- Revenue This Year
- SOTK N/A
- CRVO N/A
- Revenue Next Year
- SOTK $9.53
- CRVO N/A
- P/E Ratio
- SOTK $40.42
- CRVO N/A
- Revenue Growth
- SOTK N/A
- CRVO 15.14
- 52 Week Low
- SOTK $3.50
- CRVO $1.80
- 52 Week High
- SOTK $6.05
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- SOTK 50.01
- CRVO 51.63
- Support Level
- SOTK $3.63
- CRVO $5.45
- Resistance Level
- SOTK $3.78
- CRVO $7.55
- Average True Range (ATR)
- SOTK 0.13
- CRVO 0.59
- MACD
- SOTK 0.00
- CRVO 0.14
- Stochastic Oscillator
- SOTK 52.38
- CRVO 75.71
About SOTK Sono-Tek Corporation
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.